Plain-English translation Regenerative Medicine
Royal College British Orthopaedic AO Trauma Churchill Limb Recon Specialist Reg.

Heidari N, Slevin M, Zeinolabediny Y, Meloni D, Olgiati S, Wilson A, et al.. Comparison of the Effect of MFAT and MFAT + PRP on Treatment of Hip Osteoarthritis: An Observational, Intention-to-Treat Study at One Year. Journal of Clinical Medicine, 2022.

Comparison of the Effect of MFAT and MFAT + PRP on Treatment of Hip Osteoarthritis: An Observational, Intention-to-Treat Study at One Year

Heidari N, Slevin M, Zeinolabediny Y, Meloni D, Olgiati S, Wilson A, et al.. — Heidari N: First Author

This is a plain-English translation of the academic paper above, prepared for patients, referring clinicians, and other non-specialist readers. It preserves the structure of the original paper while removing technical jargon. For the full clinical paper, follow the PubMed or DOI links.

Background

Whether two injection treatments for painful hip arthritis — an injection of micro-fragmented adipose tissue (MFAT, a small amount of the patient’s own fat) on its own, or MFAT mixed with platelet-rich plasma (PRP, a concentrate from the patient’s own blood) — produced different results at one year.

Rationale

Hip osteoarthritis is a major cause of pain, lost mobility, and time off work. Some patients are not yet ready for hip replacement, or want to delay it. Biological injections are emerging as a way to ease pain and possibly slow the wear of the joint, but it is not yet clear which preparation works best.

Results

147 patients with hip arthritis (grades 1 to 4) had one of the two injections and were followed for a year. Both groups showed meaningful improvements in pain and in function. More than 60% of patients reported a 20-point or greater drop in their pain score — a clinically important change. The results were broadly similar between the two treatments, although adding PRP may help in patients with a low body mass index, where it can be hard to harvest enough fat for an MFAT-only injection.

Implications

For people with hip arthritis who are not yet at the point of joint replacement, this study suggests that an MFAT injection — with or without PRP — may meaningfully reduce pain and improve function for at least a year. The study cannot tell us whether the effect lasts longer, or how it compares to surgery; further research is needed.

Source: Heidari N, Slevin M, Zeinolabediny Y, Meloni D, Olgiati S, Wilson A, et al.. Comparison of the Effect of MFAT and MFAT + PRP on Treatment of Hip Osteoarthritis: An Observational, Intention-to-Treat Study at One Year. Journal of Clinical Medicine 2022;11(4). doi:10.3390/jcm11041056

Read full open-access paper (PDF) → Read original on PubMed → ← Back to research library